Skip to main content
. 2017 Jul 24;14(4):4011–4020. doi: 10.3892/ol.2017.6659

Figure 3.

Figure 3.

Association between combinations of COUP-TFII and LXR expression and survival of patients with colorectal cancer. Kaplan-Meier OS curves for 707 colorectal cancer patients, according to the expression levels of COUP-TFII and LXR in combination. OS rates are indicated in each panel. OS, overall survival; COUP-TFII, chicken ovalbumin upstream promoter-transcription factor II; LXR, liver X receptor.